Candida auris: a worrisome, globally emerging pathogen

Expert Review of Anti-infective Therapy
Bhagyashri D NavalkelePranatharthi Chandrasekar

Abstract

Candida auris is a recently discovered, rapidly emerging fungal pathogen. Infections due to C. auris are hospital-acquired, multidrug resistant and associated with high mortality. Areas covered: This review highlights epidemiology, pathogenesis, microbiological characteristics, clinical presentation, diagnostic challenges and treatment options of C. auris infections. Infection prevention measures to prevent spread of C. auris and special measures during an outbreak situation have also been reviewed. Expert commentary: Rapid emergence of hospital onset C. auris is worrisome. Early diagnosis of C. auris is essential for better outcomes and the implementation of infection prevention measures. Lack of widespread awareness, absence of general availability of diagnostic testing methods, and limited options for treatment of C. auris infections make it a difficult-to-treat pathogen. Further studies are needed for better understanding of this emerging pathogen.

References

Dec 1, 2001·Trends in Microbiology·K Haynes
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mi-Na KimDong Wook Ryang
Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Nov 22, 2012·Expert Review of Clinical Immunology·Małgorzata MikulskaClaudio Viscoli
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Mar 13, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O A CornelyA J Ullmann
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
Apr 18, 2015·Journal of Infection in Developing Countries·Dharmendra KumarRagini Tilak
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Sep 9, 2015·BMC Genomics·Sharanya ChatterjeeUtpal S Tatu
Nov 10, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Anupam PrakashAnuradha Chowdhary
Jan 27, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Feb 27, 2016·Journal of Clinical Psychology in Medical Settings·Samuel H Hubley, Benjamin F Miller
Jun 16, 2016·Journal of Pain & Palliative Care Pharmacotherapy· Centers For Disease Control And Prevention Public Health Service U S Department Of Health And Human Services
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Sep 17, 2016·The Journal of Hospital Infection·A ChowdharyJ F Meis
Oct 8, 2016·Journal of Microbiology and Biotechnology·Tae-Hyoung KimMi-Kyung Lee
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Nov 25, 2016·Journal of Clinical Microbiology·Masako MizusawaSean X Zhang
Dec 17, 2016·Emerging Infectious Diseases·Soraya E Morales-LópezJosé Y Rodríguez
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Jan 19, 2017·Emerging Infectious Diseases·Leighann SherryRiina Rautemaa-Richardson
Jan 31, 2017·Revista iberoamericana de micología·Alba Cecilia Ruiz GaitánJavier Pemán
Feb 17, 2017·Medical Mycology·Andrew M BormanElizabeth M Johnson
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyAnup Ghosh
Apr 6, 2017·Mycoses·Hyoung Il ChoiJun Seong Son
May 19, 2017·MMWR. Morbidity and Mortality Weekly Report·Sharon TsayBrendan R Jackson
May 19, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marwan M AzarVirginia M Pierce
May 26, 2017·Journal of Clinical Microbiology·Milena KordalewskaDavid S Perlin
Jun 7, 2017·Antimicrobial Agents and Chemotherapy·Alexander J LepakDavid R Andes
Aug 11, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer L CadnumCurtis J Donskey

❮ Previous
Next ❯

Citations

Apr 4, 2018·Antimicrobial Agents and Chemotherapy·Virginia BassoMichael E Selsted
Nov 24, 2017·Future Microbiology·Glauber R de S AraújoSusana Frases
Nov 8, 2017·Expert Review of Anti-infective Therapy·Matthew William McCarthy, Thomas J Walsh
Oct 17, 2018·Expert Review of Anti-infective Therapy·Matthew W McCarthy, Thomas J Walsh
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
May 15, 2018·Frontiers in Immunology·Gloria Hoi Wan TsoNorman Pavelka
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
May 23, 2020·Infection and Drug Resistance·Muluneh Ademe, Friehiwot Girma
Nov 7, 2018·Journal of Intensive Care·Andrea CortegianiAnuradha Chowdhary
Apr 20, 2019·Frontiers in Cellular and Infection Microbiology·Haroldo Cesar de OliveiraOscar Zaragoza
Aug 20, 2019·Internal Medicine Journal·Chong W OngUNKNOWN Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HIC
Aug 30, 2019·The Journal of Laryngology and Otology·R K Jackler, T A Jan
Oct 30, 2020·Journal of Fungi·Virginia BassoMichael E Selsted
Dec 23, 2020·Journal of Fungi·Irene Jurado-MartínElena Eraso
Feb 19, 2021·Journal of Medical Microbiology·Arunaloke Chakrabarti, Prashant Sood
May 1, 2021·International Journal of Molecular Sciences·Lucia ČernákováCélia F Rodrigues
Aug 3, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Balaji PathakumariWeida Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Marwan M AzarVirginia M Pierce
© 2021 Meta ULC. All rights reserved